chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Out of energy more often than he did before receiving the vaccine; Shortness of breath; Tickle in his chest and felt that he needed to laugh code; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Shortness of breath), ASTHENIA (Out of energy more often than he did before receiving the vaccine) and PARAESTHESIA (Tickle in his chest and felt that he needed to laugh code) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Jan-2021, the patient experienced PARAESTHESIA (Tickle in his chest and felt that he needed to laugh code). On 13-Jan-2021, the patient experienced DYSPNOEA (Shortness of breath). On 05-Feb-2021, the patient experienced ASTHENIA (Out of energy more often than he did before receiving the vaccine). At the time of the report, DYSPNOEA (Shortness of breath), ASTHENIA (Out of energy more often than he did before receiving the vaccine) and PARAESTHESIA (Tickle in his chest and felt that he needed to laugh code) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Adverse reaction after receiving the COVID-19 vaccine in Vaccine Clinic.   Medications: No current outpatient medications on file.    Allergies: Not on File   Medical history: No past medical history on file.  This was vaccine dose 2 of the Pfizer COVID-19 vaccine.   Describe adverse reaction: Dizziness. Employee was monitored for 40 minutes.   Anaphylaxis symptoms: Dizziness  Anaphylaxis plan: Provided water, juice and crackers, monitoring on gurney  Vasovagal symptoms: dizziness  Vasovagal plan: offer water  Administration error: n/a   MERT called No  Transferred to Home  VAERS report number: Report online   Email sent to Clinic and patient documented in adverse reaction log.
I developed a mild case of shingles 2 weeks after my first Pfizer shot (3/30/21). Yesterday I read a news report about research in Israel identifying shingles as a possible side effect to the first Pfizer shot. I also heard several TV news reports about shingles appearing as a side effect to the first Pfizer shot.  A link to the news report I found is enclosed.
Zoster vaccine was given to the patient instead of Varicella vaccine. Patient had no reaction 40 minutes post vaccine administration. She did not have any reactions by 9:30 am on 8/18/2017.
swollen limph node in the left side of the neck; Pregnant; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (swollen limph node in the left side of the neck) and MATERNAL EXPOSURE DURING PREGNANCY (Pregnant) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On 20-Apr-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Pregnant). On 30-Nov-2021, the patient experienced LYMPHADENOPATHY (swollen limph node in the left side of the neck). At the time of the report, LYMPHADENOPATHY (swollen limph node in the left side of the neck) and MATERNAL EXPOSURE DURING PREGNANCY (Pregnant) outcome was unknown.            No concomitant and treatment medications were reported
Sudden sore throat, hoarseness, followed by severe nausea, vomiting, fever 101, severe chills icy cold extremities.
Covid-19; Covid-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 46-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 30Jun2021 at 12:00 as dose number unknown, single (Batch/Lot number: unknown) (Vaccine lot unknown: True, Vaccine lot unknown reason: Misplaced/discarded, Vaccine dose number unknown: True, Vaccine dose number unknown reason: Unknown) at the age of 45 years, in left arm for covid-19 immunisation; coviD-19 vaccine mrna (mrna 1273) (MODERNA COVID-19 VACCINE), on 19Jan2022 at 12:00 as dose number unknown, single (Batch/Lot number: unknown) (Vaccine brand unknown: False, Vaccine lot unknown: True, Vaccine lot unknown reason: Misplaced/discarded, Vaccine dose number unknown: True, Vaccine dose number unknown reason: unknown) in left arm for covid-19 immunisation. The patient's relevant medical history included: "Obesity" (unspecified if ongoing). There were no concomitant medications in 2 weeks. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Covid-19". Anti-viral details: Product=COVID 19 Treatment, Brand=Paxlovid, Treatment start date: 04May2022, Treatment Stop date: 09May2022, Indication: Treatment of COVID-19. Adverse event: Relapse. Negative on 10May2022, positive again 13May2022 with cold symptoms. Adverse event country:, Adverse event start date: 13May2022, Adverse event start time: 12:00 PM. If patient was not Recovered. If treatment ae: No. Known allergies: No. The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) Positive; (10May2022) Negative; (13May2022) Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19. The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.  The information on the batch/lot number for (BNT162B2), has been requested and will be submitted if and when received.
Patient also reports having a sore arm after receiving the vaccine; This is a spontaneous report from a contactable physician. A 62-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration on an unspecified date at single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Patient had both doses of the Pfizer covid vaccine. 19 days since second dose. Had blood drawn yesterday and came back negative- Quest Sars Cov 2 serology IGG antibody test with NEG result with no numerical result. Then took finger stick rapid IGm and IGG test that was negative for both as well. The patient experienced patient also reports having a sore arm after receiving the vaccine on an unspecified date. The Outcome of the event was unknown.
8-25-2011 Pt. was given 1st GARDASIL, advised of waiting time. Pt. wanted to leave but started to c/o lightheaded instr. to go back to exam room. Vitals checked & noted low BP, pt. lying down & then started w/ tonic-clonic seizure. Had Hx of seizures but not current problem, no meds pt stabilized in office. Called 911, sent to hospital.
Extreme irritability, up most of the night, post vax, crying inconsolably. Short periods of sleep followed by another hour or so of crying the next morning. Resolved by late morning.
Twelve days after COVID vaccination patient broke out in a rash over most of body.   Called Public Health nurse who referred him to his PMD.  Patient told would be reported to CDC.
Body aches, high fever, chills, and diarrhea that lasted for a week. No medical treatment other than taking a few Tylenol.
Bilateral Swollen lymph nodes in armpits, joint pain in spine and lower back/hips.
Erectile dysfunction and very low libido.  My father is experiencing the exact same problem after his 2nd Pfizer shot.  I am 19, in great physical shape, work out every day, in perfect health.  This i; extreme depression.; very low libido.; This is a spontaneous report from a contactable consumer (patient). A 19-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration, administered in Arm Right on 01Jun2021 16:00 (Batch/Lot number was not reported) as DOSE 2, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient had no previous COVID-19 prior to vaccination and not COVID-19 tested post vaccination. The patient received the first dose of bnt162b2 on 11May2021 16:00 in the right arm for COVID-19 immunization. The patient reported of Erectile dysfunction and very low libido on 03Jun2021, 08:00 AM. The patient added that: "My father is experiencing the exact same problem after his 2nd Pfizer shot.  I am 19, in great physical shape, work out every day, in perfect health.  This issue has been ongoing for 4 months now and is causing extreme depression (as reported).  Please start investigating what the vaccine is doing to cause this.  I keep hearing that the vaccine doesn't cause ED, but it did for both me and my father.  This is not being caused by any mental duress.  It is a physical problem. " Treatment includes Viagra, Cialis (both did not work). The events resulted in Doctor or other healthcare professional office/clinic visit. The outcome of the events was not recovered.   The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Pt developed a 6" X 5" induration with warmth to the right thigh.
This spontaneous report was received from healthcare worker (certified medical assistant), refers to multiple unspecified patients of unknown age and gender. Medical history, concurrent conditions and concomitant medications were not reported. On an unknown dates, patients were vaccinated with improperly stored VARIVAX (Merck) injection, lot # L036830, expiry date 24-SEP-2017, (dose, frequency and route of administration not reported). No adverse effects reported. No product quality complaint (PQC) was involved. NO further information was provided. Additional information has been requested.
Patient is 83-year-old male with past medical history COPD (not on home oxygen), DM2, HTN, HLD,  history of lung cancer,  hx of pneumonia, and hx of TIA (treated with Plavix) who presents to the ED due to a 2 day history of diarrhea and low oxygen.  Patient was recently seen in the ED x 3 days ago for diffuse body aches and pain, fatigue, chills and diaphoresis as patient describes as " flu-like symptoms." Patient was tested positive for COVID that day.  Patient maintained SpO2 95% on room air and he was discharged home.  Patient states he did not receive any discharge medications but was advised to return if symptoms worsened.  Patient states that the next day he began to have diarrhea and his home pulse ox display  displayed an SpO2 80%.  Patient return to the ED with his wife.  Patient states his main concern is the diarrhea, denies shortness of breath, chest pain, fever, body aches, nausea, vomiting, chills.  Upon arrival to the ED patient was started on 4L NC O2.  Of note, patient is COVID vaccinated and received the COVID booster shot.  Not on home Oxygen   Currently in the hospital on 01/05/2022 in the COVID stepdown unit.  01/05/2022 note:  Patient seen and examined at bedside labs and chart are reviewed.  Patient states he is doing much better, and his diarrhea has resolved. Patient states he is ready to go home. Currently on 2L O2 NC.  Disposition: Patient is afebrile and stable.  Clinical condition is improving. Will need to consult Case manager for home Oxygen prior to discharge.
No taste; Migraine; Fever; This is a spontaneous report from a non-contactable consumer (patient herself). A 45-year-old non-pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/lot number: Unknown and Expiration date: Unknown), via an unspecified route of administration on 30Jan2021 (at the age of 45-year-old) at single dose for COVID-19 immunisation in hospital. The patient's medical history was unknown. It was unknown whether the patient had allergies to medications, food, or other products or not. Concomitant medications were not reported. The patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/lot number: Unknown and Expiration date: Unknown), on 09Jan2021 (at the age of 45-year-old) at single dose for COVID-19 immunisation and felt tired, lethargic all weekend. It was unknown whether the patient received any other vaccines within 4 weeks prior to the COVID vaccine or not. The patient was not diagnosed with COVID-19 prior to vaccination. It was unknown whether the patient has been tested for COVID-19 since the vaccination or not. On 30Jan2021, the patient experienced no taste, fever and migraine. The patient underwent lab tests and procedures included body temperature: Fever on an unspecified date. The events were considered as non-serious by the consumer. No treatment received for the adverse events. The outcome of the events was recovered on an unspecified date in 2021.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Developed red swollen area to left arm at site of varicella. Vomiting began 9-29-09; nausea and abd. pain.
Client received Pfizer booster of 0.3ml (Lot # FD7218)) on 12/21 around 9:50am. Previous doses were given by other organization on 4/20/21 and 5/11/21. At approximately 9:55am, client was sitting in monitoring area next to her father. Her father reports client was talking to him, when she slumped over, dropped her phone, and couldn?t hold her head up. She then proceeded to bring curled hands to her chest, and exhibited clonic type movements for approximately 10 seconds. She then began hyperventilating and slowly ?came to.?  Client?s father shared client had no history of seizures, nor any known allergies. Client is not on any medications. EMS was alerted at 10:03am. Vital signs at 10:03am were: BP 116/82; HR 76; RR 20. Client oriented to person, place, time, and event.   At 10:11 vital signs were BP 90/60; HR 68; RR 24. EMS arrived at 10:12am. Client continued to be alert and oriented. Shared her hands were ?clammy,? and prior to event felt ?light headed.? Client ambulated with assistance to EMS stretcher with planned transport to hospital.
Knot in cubital fossa; This spontaneous case was reported by a consumer and describes the occurrence of JOINT SWELLING (Knot in cubital fossa) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, the patient experienced JOINT SWELLING (Knot in cubital fossa). At the time of the report, JOINT SWELLING (Knot in cubital fossa) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment was received by the patient.  No concomitant medication was received by the patient.   Most recent FOLLOW-UP information incorporated above includes: On 06-Jul-2021: Follow up was received on 06-JUL-2021: contains non significant information.
Initial information received on 25-Oct-2018 regarding an unsolicited valid non-serious case received from a other healthcare professional. This case involves a nine-weeks old female patient who received a dose of 0.25 ml of FLUZONE QUADRIVALENT (lot number: UJ005AF and expiration date: 30-Jun-2019) via intramuscular route in the right thigh on 25-Oct-2018. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included PENTACEL for Immunisation; PNEUMOCOCCAL VACCINE CONJ 13V (CRM197) for Immunisation; ROTATEQ for Immunisation; and HEPATITIS B VACCINE on an unknown date. It was a case of actual medication error due to inappropriate age at vaccine administration because a 9 week baby was administered the vaccine. It was unknown if any adverse event was occurred or not following the vaccination. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error. Documents held by sender: none.
Pt. is a 65 Y female who reports that after she got her vaccines on 2/24 she was a little bit nauseated. She came home and felt very tired. She took a COVID test and it was negative. She started to see some swelling on the left side of the face last night. It was very pronounced and her left eye was nearly shut due to the swelling. It has gone down since yesterday. No rash. No difficulty breathing. No irritation of her throat. She did run a little fever yesterday into today.  She did not take any photos. Today she feels there is still a little bit of swelling but not much.
Event occurred after 2nd vaccine. First vaccine was on 2/23/21 and the second one on 3/23/21. Pt tested positive for COVID-19 on  11/24/21.
Hematoma to right thigh.  Size smaller than a pea, no redness or swelling.  Treatment:  warm compresses and massage.
Steven Johnson Syndrome; Blisters on his feet; His hands started peeling; This is a spontaneous report from a contactable consumer (patient's child). A 62-year-old male patient received first dose of bnt162b2 (BNT162B2), via an unspecified route of administration, administered in Arm Left on unknown date in Jul2021 at 12:45 (Lot number was not reported) as single dose (at age of 62-year-old) for covid-19 immunisation. Medical history included chronic obstructive pulmonary disease (COPD), emphysema. Patient had no known allergies. Concomitant medications received within two weeks of vaccination included budesonide, formoterol fumarate (SYMBICORT); paracetamol (TYLENOL). The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Patient did not have COVID prior vaccination. No COVID tested post vaccination. On 30Jul2021 17:00 patient experienced steven johnson syndrome, blisters on his feet, his hands started peeling. It was reported that patient started out with blisters on his feet and then his hands started peeling. His doctor called it Steven Johnson Syndrome. Events resulted in Doctor or other healthcare professional office/clinic visit. Patient was treated for the events, steroids were prescribed. Patient had not recovered from the events, at the time of the report.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Patient ran a fever of 102 for 3 days.  Wouldn't eat. Extremely fussy.  Lethargic, non active.  Treatment was tylanol administered every 4 hours, but didn't drop the fever.
Patient had diarrhea and was fussy that night. That subsided over the next 12-24 hours. However, then 3 days later (yesterday) the patient developed a small nodule at the site of the injection. He has remained well-appearing without signs of lethargy or infection, just the small swelling near the injection site.
Patient stated she developed a rash and her arm began to swell at injection site. She complained of having pain around area.
This spontaneous report as received from a healthcare worker refers to a 70 years old female patient with IV dye allergy and no pertinent medical history. The patient was vaccinated SC with a 0.5 ml dose of PNEUMOVAX23 (lot # 672074/1502AA, Exp. Date: 19-MAY-2013) on 18-OCT-2012. No other co-suspects were reported. Concomitant medications included calcium (unspecified), krill oil, LIPITOR, vitamins (unspecified), VASOTEC and aspirin. On an unknown date the patient developed impetigo after receiving PNEUMOVAX23. The patient saw the physician for medical attention. No treatment was given for the event. The outcome of impetigo was reported as recovered. Additional information has been requested.
Swelling, itching, soreness, and redness along with pain beginning within hours of injection, symptoms continued to next day(s), patient reported fever and chills the day after vaccination, treatment with BENADRYL helped with symptoms.
SEVERLY HEAVY MENSTRUAL CYCLE. AS OF RIGHT NOW JUST SEEING HOW THINGS GO. IF THEY DONT IMPROVE OVER THE COURSE OF THE DAY WILL BE SEEING A MEDICAL PROVIDER.
By the late evening of date of injection my arm was very red, sore, hot, hard, swollen and very painful. The next early morning I couldn't get up. I had a fever, headache (strong), muscle pain, my arm was swollen from the elbow to the shoulder, and I was very weak! It took be 3 days to recuperate. I called the pharmacist and she told me the side effects were normal and a good sign that I had a strong immune system which was trying to fight the vaccine. I slept all Monday and part of Tuesday. I took TYLENOL every six hours for 3 days. Today is 4 days after the vaccine, and the redness and swelling are almost gone except on the underarm area closer to the elbow. I still have a headache-although bearable-and feel tired.
Muscle pain in shoulders with more extreme pain in the left shoulder, Left wrist. This muscle pain occurred on March 16 and dissipate 2 days later. Then on March 18, 2021 I started to feel muscle pain and swelling in and around my left ankle. On March 20th, 2021 the swelling  remain in and around the ankle but the swelling and pain migrated to  the first joint of my left big toe. The pain on a scale of 1 to 10 ten is about a 3. The pain elevate to a 10 when touched. Pain is unbearable if I attempt walking on the left leg, as a result I am not able to walk. Swelling has not subsided in 3 days
malaise; muscle aches; fever; This case was reported by a consumer via call center representative and described the occurrence of malaise in a 70-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced malaise, muscle pain and fever. On an unknown date, the outcome of the malaise, muscle pain and fever were unknown.   It was unknown if the reporter considered the malaise, muscle pain and fever to be related to Shingrix.     Linked case(s) involving the same patient: US2023015620   Additional Information: GSK Receipt Date: 01-FEB-2023 Reporter's Comment: The case was self-reported by the patient. The patient received first dose of Shingrix and developed malaise, muscle aches and fever several months ago reporting. Nothing else was reported. The reporter did not consent to follow up. Additional Supportive Information: For tolerance of 2nd dose, refer case US2023015620, reported by same reporter.; Sender's Comments:  US-GSK-US2023015620:Same reporter/Same patient
Received vaccine at 9am 1/6/22, then 15 hours later (12am 1/7/22) developed fever 104, vomiting, headache. fevers lasting 4-5 days. vomiting and headache intermittently 4-5 days as well.
This case was reported by a healthcare professional and described the occurrence of hepatitis B surface antigen positive in a female subject of unspecified age who was vaccinated with ENGERIX B (GlaxoSmithKline). Concurrent medical conditions included exposure via blood. On an unspecified date, the subject received unspecified dose of ENGERIX B (unknown route and injection site) due to a blood exposure. 1 day after vaccination with ENGERIX B, the subject experienced hepatitis B surface antigen positive. At the time of reporting, the outcome of the event was unspecified. This is one of the 2 cases reported by the same reporter.
Information has been received from a company representative concerning a 4 year old female who on 7/27/00 was vaccinated with a dose of MMRII. Subsequently, the pt experienced a rash and welts. Additional information has been requested.
Headache,  a little short of breath. Took a Benadryl, was fine the next day.